Stockscreener 앱 받기
1.20
2.44%
-0.03
시간 외 거래:
1.76
0.56
+46.67%
전일 마감가:
$1.23
열려 있는:
$1.18
하루 거래량:
35,510
Relative Volume:
0.45
시가총액:
$12.74M
수익:
$3,000
순이익/손실:
$-8.54M
주가수익비율:
-0.6956
EPS:
-1.7252
순현금흐름:
$-7.51M
1주 성능:
-5.51%
1개월 성능:
+3.45%
6개월 성능:
+3.45%
1년 성능:
-53.49%
1일 변동 폭
$1.18
$1.28
1주일 범위
$1.18
$1.41
52주 변동 폭
$1.00
$3.20
Biocardia Inc Stock (BCDA) Company Profile
명칭
Biocardia Inc
전화
650-226-0123
주소
320 SOQUEL WAY, SUNNYVALE, CA
Compare BCDA vs MOBBW, PSNYW, GOODO, SHMD, DWLD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| 0.41 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
2.52 | 3.71B | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
4.58 | 414.42M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
19.91 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
6.52 | 377.54M | 52.15M | -21.46M | 0 | -0.4675 |
|
DWLD
Davis Select Worldwide ETF
|
43.90 | 0 | 0 | 0 | 0 | 0.00 |
Biocardia Inc Stock (BCDA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-04-16 | 다운그레이드 | Dawson James | Buy → Neutral |
Biocardia Inc 주식(BCDA)의 최신 뉴스
Quarterly Risk: Does BioCardia Inc stock have upside surprise potential2026 Technical Overview & Expert Approved Trade Ideas - baoquankhu1.vn
FDA accepts BioCardia pre-submission for Helix catheter By Investing.com - Investing.com South Africa
BioCardia Inc Announces Pre-Submission Approval Package for Helix Transendocardial Delivery Catheter Accepted by FDA - marketscreener.com
BioCardia Announces FDA Review of Helix Transendocardial Delivery Catheter Pre-Submission Package – Key 2026 Regulatory Milestones - Minichart
FDA accepts BioCardia pre-submission for Helix catheter - Investing.com
BioCardia (BCDA) Advances Heart Catheter Approval with FDA Submi - GuruFocus
BioCardia Advances Helix Catheter Toward FDA Marketing Clearance - TipRanks
BioCardia Announces Pre-Submission Approval Package For Helix Transendocardial Delivery Catheter Accepted By FDA - TradingView
BioCardia Announces Pre-Submission Approval Package for Helix Transendocardial Delivery Catheter Accepted by FDA - The Manila Times
BioCardia® Announces FDA Acceptance of Pre-Submission Package for Helix Transendocardial Delivery Catheter - Quiver Quantitative
FDA accepts BioCardia (NASDAQ: BCDA) Helix catheter pre-submission for review - Stock Titan
BioCardia Announces Pre-Submission Approval Package for - GlobeNewswire
Chart Watch: Is now the right time to enter BioCardia IncDay Trade & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
BCDA Stock Price, Quote & Chart | BIOCARDIA INC (NASDAQ:BCDA) - ChartMill
Aug Reactions: Can BioCardia Inc ride the EV wave2026 Performance Recap & Real-Time Stock Entry Alerts - baoquankhu1.vn
Weekly Recap: Is BioCardia Inc a momentum stock2026 Analyst Calls & Risk Managed Investment Entry Signals - baoquankhu1.vn
BioCardia files prospectus for resale of 549K shares; stock down 8.6% - MSN
Market Outlook: Whats the profit margin of BioCardia IncJuly 2025 EndofMonth & Weekly Top Stock Performers List - baoquankhu1.vn
BioCardia Late Breaking Echocardiography Clinical Results from CardiAMP HF Trial Presented at Technology and Heart Failure Therapeutics (THT) - Bitget
BioCardia Highlights Positive CardiAMP Phase III Heart Failure Data - TipRanks
BioCardia reports positive echocardiography results from Phase III CardiAMP HF trial indicating reduced ventricular remodeling - TradingView
New CardiAMP HF echo data from BioCardia (NASDAQ: BCDA) highlight ventricular remodeling - Stock Titan
Heart failure cell therapy shows less adverse cardiac remodeling - Stock Titan
BCDA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BCDA Should I Buy - Intellectia AI
Loss Report: Can BioCardia Inc ride the EV wavePortfolio Profit Report & Daily Growth Stock Tips - baoquankhu1.vn
BioCardia (NASDAQ:BCDA) Trading Up 3.1% – Here’s Why - Defense World
Chipmakers Recap: Does BioCardia Inc have pricing powerQuarterly Performance Summary & Fast Gaining Stock Reports - baoquankhu1.vn
S P Trends: Can BioCardia Inc. ride the EV waveMarket Trend Review & Verified Short-Term Plans - mfd.ru
BCDA PE Ratio & Valuation, Is BCDA Overvalued - Intellectia AI
How is BioCardia Inc. managing supply chain issuesMarket Volume Summary & Weekly Top Performers Watchlists - mfd.ru
Biocardia's Regulatory Milestone: FDA Submission Paves Way for Cardiac Delivery System () - aktiencheck.de
BioCardia submits FDA pre-submission for heart delivery catheter By Investing.com - Investing.com Nigeria
Biocardia files pre-submission for FDA approval of Helix(TM) - marketscreener.com
BioCardia (BCDA) Advances Helix Catheter Approval with FDA Pre-S - GuruFocus
BioCardia submits FDA pre-submission for heart delivery catheter - Investing.com
BioCardia Advances FDA Pathway for Helix Delivery Catheter - TipRanks
BioCardia Submits Pre-Submission to FDA for Helix Transendocardial Delivery Catheter Approval - Quiver Quantitative
BioCardia Files Pre-Submission for FDA Approval of Helix™ Transendocardial Delivery Catheter for Therapeutic and Diagnostic Agent Delivery to the Heart - marketscreener.com
BioCardia Files Pre-Submission for FDA Approval of Helix™ - GlobeNewswire
Insider Buying: Peter Altman Acquires Additional Shares of BioCa - GuruFocus
BioCardia’s CardiAMP Heart Failure Data Selected for LBCT - TipRanks
BioCardia Announces Late Breaking Echocardiography Results from the CardiAMP HF Trial to be Presented at Technology and Heart Failure Therapeutics (THT) - The Manila Times
BioCardia, Inc. Announces Presentation of CardiAMP HF Trial Data - TradingView
Heart failure cell therapy trial lands late-breaking THT slot for echo data - stocktitan.net
Insider Sell: Will Matador Resources Company benefit from geopolitical trendsDividend Hike & Weekly Momentum Stock Picks - baoquankhu1.vn
Activity Recap: Does BioCardia Inc have consistent dividend growthQuarterly Trade Review & Growth Oriented Trade Recommendations - baoquankhu1.vn
Aug Ideas: Whats Sono Tek Corporations historical returnPortfolio Value Report & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
Chipmakers Recap: Should you avoid BioCardia Inc stock right now2025 Earnings Impact & Safe Swing Trade Setup Alerts - baoquankhu1.vn
IO Biotech (IOBT) Explores Strategic Alternatives, Stock Surges 19.36% - Intellectia AI
Altman Peter buys BioCardia (BCDA) shares worth $1,194 By Investing.com - Investing.com Nigeria
Biocardia Inc (BCDA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):